Biochemical Engineering Special Interest Group
biological engineering professionals
18 April 2017

Circassia scraps allergy program after another trial flops

Circassia has pulled the plug on its allergy programs after falling short in another study. The string of failures continued with the publication of subpar data from a house dust mite allergy phase 2b, forcing the company to pivot away from the assets that drove it to a £200 million ($251 million) IPO in 2014. Source: Fierce Biotech 18/4/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).